newsmetry
rusign inget started
macro

TD Cowen keeps Buy on SpaceX with $224 target after strong Q3

TD Cowen reaffirmed its Buy rating on SpaceX with a $224 price target, implying 51.6% upside from the October 20 close of $147.79 per share.

published on Newsmetry
original source published

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

Newsmetry newsroom

what happened

Analysts at TD Cowen kept their Buy rating on SpaceX stock and set a price target of $224. By their estimate, this implies a 51.6% gain from the October 20 closing price of $147.79. TradingView, citing Benzinga data, reports that the company's revenue rose 161% year over year in the third quarter of 2026. The Super Intelligence segment drove 75% of that growth. The result beat both TD Cowen's forecast and the consensus estimate.

The note also says the firm raised its revenue and EBITDA projections for 2026 to 2031 by 21% and 26% a year, respectively. The outlook rests on SpaceX's ability to scale its Super Intelligence compute leasing and grow its other businesses.

why it matters

For investors, the key point is the expected growth in revenue and earnings from the Super Intelligence business. Other brokers' targets, including those from Cantor Fitzgerald, Macquarie and Needham, range from $200 to $345, which shows wide disagreement among analysts about the stock.

tags

Analyst RatingStockUnited States

instruments

SPCXSpaceX

sources

  1. TD Cowen maintains Buy rating on SpaceX, $224 price target — TradingView, 21 October 2026 at 12:23 UTC
  2. TD Cowen maintains Buy rating on Capital One Financial, $250 price target — TradingView, 21 October 2026 at 13:37 UTC
  3. TD Cowen reiterates Buy rating on Intuitive Surgical, $485 price target — TradingView, 21 October 2026 at 13:36 UTC
  4. TD Cowen maintains Buy rating on Aurinia Pharmaceuticals, $18 price target — TradingView, 21 October 2026 at 13:51 UTC
  5. TD Cowen maintains Buy rating on Atlantic Union Bankshares, $43 price target — TradingView, 21 October 2026 at 13:49 UTC
  6. TD Cowen maintains Buy rating on Ally Financial, $52 price target — TradingView, 21 October 2026 at 13:47 UTC
  7. TD Cowen maintains Buy rating on Biogen, $250 price target — TradingView, 21 October 2026 at 13:53 UTC
  8. TD Cowen reiterates Buy rating on Celcuity, $145 price target — TradingView, 21 October 2026 at 14:45 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗

related stories